Device manufacturer, as written on reports
Livanova USA: medical device reports filed with FDA
10,393 reports name it as the manufacturer of the device involved, 2007–2026.
- 10,393
- reports naming it as manufacturer
- 0% of all MAUDE reports
- 698
- reports, 12 months to August 2026
- 869 in the 12 months before
- 57.6%
- classified as malfunction
- 62.3% across all reports
- 3.5%
- classified as death, as reported
- 0.9% across all reports
10,393 medical device reports received by FDA give Livanova USA as the manufacturer of the device involved, 0% of the MAUDE database, from April 2007 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
698 reports arrived in the 12 months to August 2026, down 20% from 869 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (57.6%), injury (38.8%) and death (3.5%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Pulse Gen Model 1000 | Stimulator, autonomic nerve, implanted for epilepsy | 2,038 | 549 | 5.7% |
| Pulse Gen Model 106 | Stimulator, autonomic nerve, implanted for epilepsy | 1,800 | 144 | 5.1% |
| Lead Model 304 | Stimulator, autonomic nerve, implanted for epilepsy | 1,430 | 272 | 0.1% |
| Lead Model 302 | Stimulator, autonomic nerve, implanted for epilepsy | 1,329 | 136 | 0% |
| Pulse Gen Model 103 | Stimulator, autonomic nerve, implanted for epilepsy | 627 | 34 | 8.5% |
| Lead Model Unknown | Stimulator, autonomic nerve, implanted for epilepsy | 394 | 46 | 1.6% |
| Pulse Gen Model 102 | Stimulator, autonomic nerve, implanted for epilepsy | 338 | 14 | 12.2% |
| Pulse Gen Model Unk | Stimulator, autonomic nerve, implanted for epilepsy | 318 | 7 | 13.6% |
| Pulse Gen Model 105 | Stimulator, autonomic nerve, implanted for epilepsy | 285 | 7 | 6.7% |
| Pulse Gen Model 104 | Stimulator, autonomic nerve, implanted for epilepsy | 230 | 4 | 9% |
| Bipol Lead Model 300 | Stimulator, autonomic nerve, implanted for epilepsy | 225 | 12 | 0.1% |
| Lead Model 303 | Stimulator, autonomic nerve, implanted for epilepsy | 209 | 28 | 0% |
| Programming Software | Stimulator, autonomic nerve, implanted for epilepsy | 180 | 1 | 0% |
| Symmetry Gen Model 8103 | Stimulator, autonomic nerve, implanted (depression) | 144 | 23 | 3.8% |
| Pulse Gen Model unknown | Stimulator, autonomic nerve, implanted for epilepsy | 101 | 40 | 10.9% |
| Lead Model 300 | Stimulator, autonomic nerve, implanted for epilepsy | 87 | 22 | 0% |
| Pulse Gen Model 102r | Stimulator, autonomic nerve, implanted for epilepsy | 65 | 0 | 10.9% |
| Lead Model Unk | Stimulator, autonomic nerve, implanted for epilepsy | 29 | 0 | 0.3% |
| Pulse Gen Model 101 | Stimulator, autonomic nerve, implanted for epilepsy | 12 | 0 | 12.6% |
| Heater-Cooler System 3t | Controller, temperature, cardiopulmonary bypass | 4 | 8 | 3.5% |
| Bipol Lead Model 302 | Stimulator, autonomic nerve, implanted for epilepsy | 2 | 0 | 0% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Livanova USA reports
How many FDA device reports name Livanova USA as manufacturer?
10,393 reports through August 2026, 698 of them in the latest 12 months.
Which of its brands appear most often?
Pulse Gen Model 1000 (2,038), Pulse Gen Model 106 (1,800), Lead Model 304 (1,430), Lead Model 302 (1,329) and Pulse Gen Model 103 (627).
Which device types does it report on?
stimulator, autonomic nerve, implanted for epilepsy (92.1%), stimulator, autonomic nerve, implanted (depression) (5.1%), tubing, pump, cardiopulmonary bypass (1.3%) and catheter, cannula and tubing, vascular, cardiopulmonary bypass (0.7%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.